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Accepted 22 January 2013AbstractObjective: To present prenatal ultrasound and molecular genetic diagnosis of Apert syndrome.
Case Report: A 30-year-old, gravida 3, para 2 woman was referred for genetic counseling at 32 weeks of gestation because of polyhydramnios
and craniofacial and digital abnormalities in the fetus. She had undergone amniocentesis at 18 weeks of gestation because of maternal anxiety.
Results of amniocentesis revealed a karyotype of 46,XX. A prenatal ultrasound at 32 weeks of gestation revealed a female fetus with a fetal
biometry equivalent to 32 weeks, polyhydramnios with an increased amniotic fluid index of 26.1 cm, frontal bossing, midface hypoplasia,
hypertelorism, Blake’s pouch cyst with an apparent posterior fossa cyst in communication with the fourth ventricle on axial images, digital
fusion, and bilateral syndactyly of the hands and feet. A DNA testing for the FGFR2 gene was immediately performed using uncultured
amniocytes obtained by repeated amniocentesis, which revealed a heterozygous c.758C>G, CCT>CGT transversion leading to a p.Pro253Arg
(P253R) mutation in the FGFR2 gene. Subsequently, a diagnosis of Apert syndrome was made. Molecular analysis of the FGFR2 gene in the
parents did not reveal such a mutation. The fetus postnatally manifested frontal bossing, midface hypoplasia, and bilateral syndactyly of the
hands (mitten hands) and feet.
Conclusion: Prenatal diagnosis of polyhydramnios, frontal bossing, and midface hypoplasia associated with brain and digital abnormalities
should include a differential diagnosis of Apert syndrome. A molecular analysis of FGFR2 using uncultured amniocytes is useful for rapid
confirmation of Apert syndrome at prenatal diagnosis.
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Apert syndrome [Online Mendelian Inheritance in Man
(OMIM): #101200] is characterized by acrocephaly, cranio-
synostosis, midface hypoplasia, and syndactyly of the hands
and feet with the bony structures exhibiting a tendency to fuse.
The disorder is caused by mutations in the fibroblast growth
factor receptor 2 (FGFR2) gene (OMIM: 176943), which is
located at 10q26.13. Most cases (98%) of Apert syndrome are
sporadic, and only a few are inherited in an autosomal
dominant pattern [1]. The S252W (p.Ser252Trp, c.755C>G,
TCG>TGG) and P253R (p.Pro253Arg, c.758C>G,
CCT>CGT) mutations account for over 98% of the cases with
Apert syndrome with approximately two-thirds of the cases
being caused by the S252W mutation and the remaining one-
third of the cases being caused by the P253R mutation [2e5].
Here, we report our experience of a rapid detection of de novo
P253R mutation in the FGFR2 gene using uncultured
amniocytes in a pregnancy affected by polyhydramnios,
Blake’s pouch cyst, and Apert syndrome.
Case report
A 30-year-old, gravida 3, para 2 woman was referred for
genetic counseling at 32 weeks of gestation because of poly-
hydramnios and craniofacial and digital abnormalities in the
fetus. Her husband was 31 years old. She and her husband
were both healthy and unrelated, and there was no family
history of congenital malformations. She had undergone
amniocentesis at 18 weeks of gestation because of maternal
anxiety. Amniocentesis revealed a karyotype of 46,XX. A
prenatal ultrasound at 32 weeks of gestation revealed a female
fetus with a fetal biometry equivalent to 32 weeks, poly-
hydramnios with an increased amniotic fluid index of 26.1 cm,
frontal bossing, midface hypoplasia, hypertelorism, Blake’s
pouch cyst with an apparent posterior fossa cyst in commu-
nication with the fourth ventricle on axial images, digital
fusion, and bilateral syndactyly of the hands and feet (Fig. 1).
A DNA testing for the FGFR2 gene was immediately per-
formed using uncultured amniocytes obtained by repeated
amniocentesis, which revealed a heterozygous c.758C>G,
CCT>CGT transversion leading to a p.Pro253Arg (P253R)
mutation in the FGFR2 gene (Fig. 2). Subsequently, a diag-
nosis of Apert syndrome was made. However, a molecular
analysis of the FGFR2 gene in the parents did not reveal such
a mutation. The woman decided to discontinue the pregnancy,
and a 2372-g female baby was delivered with frontal bossing,
midface hypoplasia, and bilateral syndactyly of the hands
(mitten hands) and feet (Fig. 3).
Discussion
The peculiar aspect of this case is the association of the
P253R mutation in the FGFR2 gene with severe syndactyly
of the hands and feet, polyhydramnios, and Blake’s pouch
cyst. A genotypeephenotype analysis in Apert syndrome hassuggested two recurrent mutations of S252W and P253R on
the severity of craniofacial abnormalities and syndactyly,
respectively [6,7]. Slaney et al [6] found that syndactyly in the
hands and feet were more severe in patients with the P253R
mutation, whereas cleft palate was significantly more frequent
in patients with the S252W mutation. von Gernet et al [7]
found higher frequency of profound midface retrusion and
severe malocclusion in patients with the S252W mutation and
higher frequency of profound severity of syndactyly in pa-
tients with the P253R mutation.
Polyhydramnios may develop in the third trimester in
pregnancies with Apert syndrome [8,9]. Chen et al [9] previ-
ously reported polyhydramnios in a pregnancy affected with
the S252W mutation, in addition to upper airway obstruction
and gastroesophageal reflux. The present case shows that a
fetus affected by the P253R mutation and a Blake’s pouch cyst
may also develop polyhydramnios in the third trimester. The
Blake’s pouch is an inferior protrusion of the fourth ventricle
into the retrocerebellar subarachnoid space resulting from a
finger-like expansion of the posterior membranous area [10].
Paladini et al [11] proposed that the diagnostic criteria of a
Blake’s pouch cyst should include (1) normal anatomy and
size of the vermis; (2) mild/moderate anticlockwise rotation of
the vermis; and (3) normal size of the cisterna magna. Paladini
et al [11] found that a Blake’s pouch cyst in the fetus is
associated with an apparently increased risk of congenital
heart disease and trisomy 21.
Polyhydramnios associated with Apert syndrome has been
suggested to be caused by decreased fetal swallowing related
to abnormalities in the central nervous system (CNS) [12].
The present case was associated with posterior fossa anomaly.
The CNS anomalies associated with Apert syndrome have
been well documented [13e21]. For example, Ferreira et al
[17] reported brain anomalies in cases with Apert syndrome
including ventriculomegaly (48.5%), hydrocephalus (9%),
gyral abnormalities, and other anomalies (e.g., agenesis
or hypogenesis of the corpus callosum, posterior fossa
anomalies) (21%). Quintero-Rivera et al [19] reported brain
anomalies in 30 cases with Apert syndrome including
nonprogressive ventriculomegaly (76%), hydrocephalus
(13%), completely absent septum pellucidum (17%), partially
absent septum pellucidum (23%), deficiency of septal leaflets
(10%), agenesis of the corpus callosum (7%), deficiency of the
corpus callosum (3%), and thinning of the corpus callosum
(13%).
Using the sophisticated sonographic observations of syn-
dactyly, midface hypoplasia, and abnormal cranial shape,
prenatal sonographic diagnosis of Apert syndrome can be
achieved in the second trimester [21e23]. However, as pre-
sented in this case, most prenatally detected cases of Apert
syndrome were reported in the third trimester because the
craniofacial and digital abnormalities and polyhydramnios
associated with Apert syndrome are more obvious only in the
late stages of gestation upon performing a prenatal ultrasound
[24]. Recently, a noninvasive prenatal diagnosis of Apert
syndrome using fetal DNA from maternal plasma by
Fig. 1. Prenatal ultrasound at 32 weeks of gestation shows (A) and (B) a Blake’s pouch cyst, (C) and (D) frontal bossing and midface hypoplasia, (E) hypertelorism,
(F) and (G) digital fusion and syndactyly of the hands, and (H) and (I) digital fusion and syndactyly of the foot.
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Fig. 2. DNA testing shows a c.758C>G, CCT>CGT, or P253R mutation in the
fetus. WT ¼ wild type.
Fig. 3. The fetus at birth. (A) Craniofacial appearance, (B) the right
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formed [25,26]. However, at present, rapid detection of the
FGFR2 mutation in suspected Apert syndrome cases on pre-
natal ultrasound using common mutation sequencing on un-
cultured amniocytes is easier and less expensive than
noninvasive prenatal diagnosis using high-throughput next
generation DNA sequencing. Therefore, we suggest perform-
ing a molecular analysis of the FGFR2 gene using uncultured
amniocytes for rapid confirmation of Apert syndrome at pre-
natal diagnosis.Acknowledgments
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